{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 11
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "07/18/2023",
      "package_ndc": "0480-3667-22",
      "generic_name": "Liraglutide Injection",
      "contact_info": "833-493-4689",
      "availability": "Available",
      "related_info": "Distributed by Teva",
      "openfda": {
        "application_number": [
          "NDA022341"
        ],
        "brand_name": [
          "LIRAGLUTIDE"
        ],
        "generic_name": [
          "LIRAGLUTIDE"
        ],
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "product_ndc": [
          "0480-3667"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "LIRAGLUTIDE"
        ],
        "rxcui": [
          "897122"
        ],
        "spl_id": [
          "57c9f463-a1b8-4efa-8982-40175cf6cf4f"
        ],
        "spl_set_id": [
          "14bf9812-14ee-46ce-93b1-686e4906cbbc"
        ],
        "package_ndc": [
          "0480-3667-19",
          "0480-3667-22",
          "0480-3667-20"
        ],
        "nui": [
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_epc": [
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "839I73S42A"
        ]
      },
      "update_date": "09/22/2026",
      "therapeutic_category": [
        "Endocrinology/Metabolism"
      ],
      "dosage_form": "Injection",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)",
      "company_name": "Novo Nordisk, Inc.",
      "status": "Current"
    }
  ]
}